New Illumina MiSeq Service Agreement

The Food and Drug Administration is preparing to issue a new service agreement for the Illumina MiSeq system to support micro surveillance activities. This upcoming contract aims to address the need for advanced sequencing services, leveraging the capabilities of the Illumina MiSeq platform. The solicitation appears to be in the forecast stage as of March 11, 2026, with further details to be determined, including the contracting officer responsible for the acquisition. The agreement falls under the NAICS code 811219, which pertains to other electronic and precision equipment repair and maintenance services. The agency has provided a program point of contact via email, while the contracting officer’s information remains pending. No specific location for performance or set-aside details have been indicated. Stakeholders interested in this opportunity can follow updates through the Food and Drug Administration’s procurement channels.